Your browser doesn't support javascript.
loading
Enhanced measures, including PCR-based screening and syndromic surveillance for nosocomial outbreaks of the COVID-19 Omicron variant, using descriptive epidemiology and whole-genome sequencing in a Japanese tertiary care hospital.
Kawamura, Hideki; Arimura, Shoko; Saida, Ryuichi; Murata, Nao; Shigemi, Akari; Kodama, Yuichi; Nakamura, Masatoshi; Obama, Yuki; Fukuyama, Ryuko; Hamada, Yuka; Shinkawa, Naomi; Sunagawa, Tomimasa; Kamiya, Hajime; Nishi, Junichiro.
Afiliación
  • Kawamura H; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan. Electronic address: hidekik@m2.kufm.kagoshima-u.ac.jp.
  • Arimura S; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Saida R; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Murata N; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Shigemi A; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Kodama Y; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Nakamura M; Clinical Laboratory, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Obama Y; Clinical Laboratory, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Fukuyama R; Clinical Laboratory, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Hamada Y; Kagoshima Prefectural Institute for Environmental Research and Public Health, 11-40 Kinko-cho, Kagoshima, 892-0835, Japan.
  • Shinkawa N; Kagoshima Prefectural Institute for Environmental Research and Public Health, 11-40 Kinko-cho, Kagoshima, 892-0835, Japan.
  • Sunagawa T; Center for Field Epidemiology Intelligence, Research, and Professional Development, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Kamiya H; Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Nishi J; Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
J Infect Chemother ; 30(2): 104-110, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37717606
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infección Hospitalaria / COVID-19 Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infección Hospitalaria / COVID-19 Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article